HUP2200147A1 - Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény - Google Patents
Palbociclibet és letrozolt tartalmazó gyógyszerkészítményInfo
- Publication number
- HUP2200147A1 HUP2200147A1 HU2200147A HUP2200147A HUP2200147A1 HU P2200147 A1 HUP2200147 A1 HU P2200147A1 HU 2200147 A HU2200147 A HU 2200147A HU P2200147 A HUP2200147 A HU P2200147A HU P2200147 A1 HUP2200147 A1 HU P2200147A1
- Authority
- HU
- Hungary
- Prior art keywords
- palbociclib
- letrozole
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- HPJKCIUCZWXJDR-UHFFFAOYSA-N letrozole Chemical compound C1=CC(C#N)=CC=C1C(N1N=CN=C1)C1=CC=C(C#N)C=C1 HPJKCIUCZWXJDR-UHFFFAOYSA-N 0.000 title 1
- 229960003881 letrozole Drugs 0.000 title 1
- AHJRHEGDXFFMBM-UHFFFAOYSA-N palbociclib Chemical compound N1=C2N(C3CCCC3)C(=O)C(C(=O)C)=C(C)C2=CN=C1NC(N=C1)=CC=C1N1CCNCC1 AHJRHEGDXFFMBM-UHFFFAOYSA-N 0.000 title 1
- 229960004390 palbociclib Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2200147A HUP2200147A1 (hu) | 2022-05-10 | 2022-05-10 | Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény |
US18/107,774 US20230364093A1 (en) | 2022-05-10 | 2023-02-09 | Pharmaceutical composition containing palbociclib and letrozole |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2200147A HUP2200147A1 (hu) | 2022-05-10 | 2022-05-10 | Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény |
US17/891,566 US11672804B1 (en) | 2022-08-19 | 2022-08-19 | Pharmaceutical composition containing palbociclib and letrozole |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP2200147A1 true HUP2200147A1 (hu) | 2023-11-28 |
Family
ID=86701297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU2200147A HUP2200147A1 (hu) | 2022-05-10 | 2022-05-10 | Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény |
Country Status (2)
Country | Link |
---|---|
US (2) | US11672804B1 (hu) |
HU (1) | HUP2200147A1 (hu) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1470124T3 (da) * | 2002-01-22 | 2006-04-18 | Warner Lambert Co | 2-(Pyridin-2-yl amino)-pyrido[2,3]pyrimidin-7-oner |
-
2022
- 2022-05-10 HU HU2200147A patent/HUP2200147A1/hu unknown
- 2022-08-19 US US17/891,566 patent/US11672804B1/en active Active
-
2023
- 2023-02-09 US US18/107,774 patent/US20230364093A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US11672804B1 (en) | 2023-06-13 |
US20230364093A1 (en) | 2023-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4183391A4 (en) | PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
IL311331A (en) | Pharmaceutical preparation and its use | |
EP3828183A4 (en) | SULFOXIMINE COMPOUND AS BROMO-DOMAIN INHIBITOR AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF | |
EP3858353A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NITM AND ASSOCIATED PHARMACEUTICAL USE | |
EP3753557A4 (en) | PREVENTIVE OR THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES OR BONE DISEASES | |
EP4005591A4 (en) | ANTINEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION | |
ZA202306105B (en) | Heart-nourishing and nerve-soothing pharmaceutical composition and method for preparation thereof and application thereof | |
EP4023227A4 (en) | PHARMACEUTICAL COMPOSITION AND ITS APPLICATION | |
EP4003332A4 (en) | PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND ITS USE FOR PREVENTING AND/OR TREATING A DISEASE | |
EP4073071A4 (en) | USE AND PHARMACEUTICAL COMPOSITION OF PHENYLISOXAZOLYL METHYLENE-NAPHTHALENE-ETHER DERIVATIVES | |
EP4103539A4 (en) | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | |
EP4095158A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ANTI-BTLA ANTIBODIES AND USE THEREOF | |
FI4110292T3 (fi) | Nestemäinen farmaseuttinen koostumus, joka käsittää ensifentriiniä ja glykopyrrolaattia | |
EP4062906A4 (en) | ORAL PHARMACEUTICAL COMPOSITION COMPRISING A CARBAMATE COMPOUND AND METHOD FOR PREPARING THIS COMPOSITION | |
HUP2200147A1 (hu) | Palbociclibet és letrozolt tartalmazó gyógyszerkészítmény | |
EP4180040A4 (en) | PHARMACEUTICAL COMPOSITION AND ITS APPLICATION | |
GB202217964D0 (en) | Pharmaceutical and cosmetic compositions comprising secretomes | |
IL312238A (en) | A pharmaceutical preparation and a kit containing an immunomodulatory agent for the treatment of diseases | |
EP4129283A4 (en) | PHARMACEUTICAL COMBINATION AND USE THEREOF | |
KR102290295B9 (ko) | 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물 | |
EP3995136A4 (en) | PHARMACEUTICAL COMPOSITION CONTAINING TAMSULOSIN OR TAMSULOSIN HYDROCHLORIDE AND METHOD FOR THE PREPARATION THEREOF | |
AU2022397653A1 (en) | Pharmaceutical composition and use thereof | |
NL2027551A (en) | 1immunogenic polypeptides and pharmaceutical compositions | |
GB202403415D0 (en) | Pharmaceutical composition | |
EP4100020A4 (en) | PHARMACEUTICAL ASPACYTARABINE COMPOSITIONS AND USES THEREOF |